2-oxa-6-azaspiro[3.3]heptane

2-oxa-6-azaspiro[3.3]heptane

2-Oxa-6-Azaspiro[3.3]heptane (CAS 174-78-7) is a compact spiro-fused bicyclic amine in which a strained oxetane ring and an azetidine ring share a single spiro carbon atom, placing one ring nitrogen and one ring oxygen in a rigid, three-dimensional scaffold of only five carbon atoms.
Send Inquiry

English synonyms :2-oxa-6-azaspiro[3.3]heptane

English synonyms:2-oxa-6-azaspiro[3.3]heptane;2-oxa-6-aza-spiro[3.3]heptane;2-Oxa-6-azaspiro[3,3]heptane;spiromorpholine;BH270;FC0232;MFCD12407093

CAS number :174-78-7

Molecular formula : C5H9NO

Molecular weight :99.13

Properties: Colorless to almost colorless clear liquid, bp 166°C, density 1.12, refractive index 1.4750-1.4790, flash point 51°C

Content: ≥97%(GC) Professional scientific accurate detection

Function: Used in foreign trade export, scientific research and chemical reagents and other fields; it is employed mainly as a compact spirocyclic building block (a rigid bioisostere of morpholine) for introducing the 2-oxa-6-azaspiro[3.3]heptane motif into kinase inhibitors and other small-molecule drug candidates in pharmaceutical research and organic synthesis.

Packing: 1G 100G 500G 1KG

Storage: Dry, sealed, protected from light under inert gas (N2 or Ar), stored at 2-8℃, shelf life of 2 years

 

Structural formula:

product-560-900

 

2-Oxa-6-azaspiro[3.3]heptane use and synthesis method

 

Intro

2-Oxa-6-Azaspiro[3.3]heptane (CAS 174-78-7) is a compact spiro-fused bicyclic amine in which a strained oxetane ring and an azetidine ring share a single spiro carbon atom, placing one ring nitrogen and one ring oxygen in a rigid, three-dimensional scaffold of only five carbon atoms. Key identifiers: molecular formula C5H9NO, molecular weight 99.13, MDL MFCD12407093, Reaxys Registry Number 18835134, InChIKey HPJALMWOZYIZGE-UHFFFAOYSA-N, InChI 1S/C5H9NO/c1-5(2-6-1)3-7-4-5/h6H,1-4H2, SMILES C1C2(CNC2)CO1, IUPAC name 2-oxa-6-azaspiro[3.3]heptane. Commercial material (e.g. TCI catalogue O0466, BLD Pharmatech, AChemBlock A-799) is a colorless to almost colorless clear liquid specified at 97-98% purity (minimum 98.0% by GC, minimum 97.0% by neutralization titration).

 

Peculiarity

The compound is valued as a spirocyclic bioisostere of morpholine: replacing a flexible morpholine ring with the rigid 2-oxa-6-azaspiro[3.3]heptane core lowers lipophilicity (XLogP -0.55) and increases aqueous solubility and three-dimensional character while retaining a solubilizing ring nitrogen (pKa 9.73 ± 0.20, predicted) and a compact polar surface (TPSA 21.3 A2). The free base is a low-boiling, flammable liquid (bp 166°C, flash point 51°C, density 1.12, refractive index 1.4750-1.4790) and is air- and heat-sensitive: in aqueous basic media the oxetane ring is prone to ring opening, so the amine is often handled and stored as a crystalline salt, most conveniently the oxalate salt (CAS 1159599-99-1). Hazard classification GHS02/GHS07 (Warning), H226 (flammable liquid and vapour), H315 (skin irritation), H319 (serious eye irritation), H335 (respiratory irritation); transport class UN 1993, class 3, packing group III; HS code 2934999090. The XLogP, pKa and TPSA figures are calculated/predicted values.

 

Uses

This compound is a synthetic intermediate, not a drug substance, and has no pharmacological activity of its own. 2-Oxa-6-azaspiro[3.3]heptane is a documented building block for bioactive substances, listed by reagent suppliers for use in the synthesis of epidermal growth factor receptor (EGFR) kinase inhibitors for cancer and leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson's disease. Its secondary amine undergoes the reactions typical of piperazine-type spacers - N-acylation, reductive alkylation, carbamate formation and Pd-catalysed (Buchwald-Hartwig) aryl amination - making it a direct substitute for morpholine or piperazine fragments in medicinal chemistry libraries, where the spirocyclic oxetane-azetidine core improves solubility and reduces metabolic liability of the resulting drug candidates.

 

Synthesis and representative transformations

The established access to this ring system starts from pentaerythritol chemistry: commercially available tribromopentaerythritol is cyclised with a sulfonamide to give 6-tosyl-2-oxa-6-azaspiro[3.3]heptane (CAS 13573-28-9), and the tosyl group is removed reductively (magnesium in methanol) to furnish the free amine. Because the free base is unstable towards oxetane ring opening under basic aqueous conditions, it is commonly converted directly into its crystalline oxalate salt with oxalic acid (CAS 1159599-99-1), and process-scale work has shown that sulfonate salts (e.g. p-toluenesulfonate) offer a robust alternative for isolation, storage and transportation of this amino oxetane. The free base should be freshly distilled or freshly liberated from its salt before use in N-functionalisation chemistry.

Starting materials: tribromopentaerythritol (cyclisation route to the spiro ring system); 6-tosyl-2-oxa-6-azaspiro[3.3]heptane (CAS 13573-28-9, reductive detosylation); oxalic acid for salt formation (oxalate CAS 1159599-99-1).

Reagents and conditions: p-toluenesulfonamide with base for ring closure; Mg/MeOH for reductive detosylation; oxalic acid or p-toluenesulfonic acid for crystalline salt formation; Pd2(dba)3/(+/-)-BINAP with KOtBu and a few drops of Et3N in toluene at 110°C for Buchwald-Hartwig amination with aryl bromides.

Representative transformations: N-acylation, reductive alkylation and carbamate (Boc/CBz) formation at the ring nitrogen; Pd-catalysed coupling with aryl bromides to give N-aryl spiro amines; acid-promoted oxetane ring opening (e.g. HBr) to functionalised bromohydrin derivatives.

Yields and specifications: Pd-catalysed aryl aminations furnish N-aryl products in 56-97% yields depending on the aryl bromide employed; commercial material is a colorless to almost colorless clear liquid specified at minimum 98.0% (GC) and minimum 97.0% (neutralization titration); store sealed under inert gas, protected from light.

Hot Tags: 2-oxa-6-azaspiro[3.3]heptane, China 2-oxa-6-azaspiro[3.3]heptane suppliers, 135575-42-7, 184177-83-1, pharma intermediates manufacturers, pharmaceutical drug development, Posaconazole Intermediate MFCD13195567, Rocuronium Bromide intermediate drug synthesis